Gilles RAULT
Fondation Ildys · Centre de Pérharidy - Roscoff
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gilles RAULT as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:34 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03304028 · MUCOviscidose EXacerbation Outils Connectés Education ThérapeutiqueInstitut National de la Santé Et de la Recherche Médicale, France · terminated · Cystic Fibrosis · principal investigator
- Ph2NCT02649751 · Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR MutationUniversity Hospital, Brest · terminated · Cystic Fibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:34 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Safety and pharmacokinetics of Roscovitine (Seliciclib) in cystic fibrosis patients chronically infected with Pseudomonas aeruginosa, a randomized, placebo-controlled study.J Cyst Fibros · 202219 citationsRCR 1.5
- [A controlled study of food behavior and emotional manifestation in a population of obese female adolescents].Arch Fr Pediatr · 199310 citationsRCR 0.5
- 1 citationsRCR 0.3